Ольга Ильиных

Inception Capital Management is a Seattle based venture capital firm focused on cancer biotechnology and late stage, brand name technology companies.

Technology is driven by innovation, new leaders emerge and become the incumbents of tomorrow. Researching and finding those unicorn companies out of thousands takes experience and skill. We specialize in the technology and biotechnology industries and consider ethical qualities and human progressive endeavors.

Cancer and Disease Eradication. Saving Lives. Molecular Biological Revolution. DNA Mastery. Longevity & Quality of Life. The Next Frontier.

Mankind's next frontiers are the Cosmos and the Microcosm. We believe that we are in the Golden Age of Biotech and some of the greatest advancements in technology and discovery will be found in the life sciences. The advancement of biotechnology in the next couple of decades will be instrumental in saving millions of lives. Our firm's focus is in cancer biotechnology.

In a world where trust has been abused at a governmental, institutional, and corporate level, a technology (blockchain) has emerged that will level the playing field and in so doing dramatically re-shape the global economy.

ID Theory provides principled and innovative exposure to cryptoassets; an emerging asset class with unparalleled asymmetric upside potential. We navigate the risks associated with this noisy and complex market for our investors.

Our thesis dictates that the salient opportunities reside within the decentralised networks that emerge from blockchain technologies. Cryptoassets are at the heart of these networks and it is their “incentive design” that is the key driver of value.